Puma Biotechnology Inc (PBYI) — Cash Flow Reinvestment Rate
Puma Biotechnology Inc (PBYI) has a Cash Flow Reinvestment Rate of 1.88x as of December 2025, reinvesting $27.05 Million (capex $36.00K plus investments $-27.01 Million) from operating cash flow of $14.42 Million. Check Puma Biotechnology Inc (PBYI) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Puma Biotechnology Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Puma Biotechnology Inc across 6 annual periods. Explore long-term investment intensity of Puma Biotechnology Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Puma Biotechnology Inc (2019–2025)
Year-by-year capital reinvestment analysis for Puma Biotechnology Inc. For live market cap and broader valuation context, see PBYI stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | $36.19 Million | $41.80 Million | $71.00K | ▲ +64.4% |
| 2024 | 0.53x | $20.49 Million | $38.92 Million | $56.00K | ▼ -59.9% |
| 2023 | 1.31x | $35.47 Million | $27.01 Million | $12.64 Million | ▲ +149.2% |
| 2021 | 0.53x | $10.88 Million | $20.65 Million | $1.00K | ▼ -99.3% |
| 2020 | 79.37x | $63.49 Million | $800.00K | $20.05 Million | ▲ +30652.5% |
| 2019 | 0.26x | $5.78 Million | $22.38 Million | $306.00K | — |